- Up-regulation of BLT2 is critical for the survival of bladder cancer cells
-
Seo JM, Cho KJ, Kim EY, Choi MH, Chung BC, Kim JH
- KMID: 1109401
- Exp Mol Med.
- 2011 Mar;43(3):129-137.
- doi: 10.3858/emm.2011.43.3.014
The incidence rates of urinary bladder cancer continue to rise yearly, and thus new therapeutic approaches and early diagnostic markers for bladder cancer are urgently needed. Thus, identifying the key... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: A comparative immunohistochemical study
-
Makboul R, Refaiy AE, Badary FA, Abdelkawi , Merseburger AS, Mohammed R
- KMID: 2070266
- Korean J Urol.
- 2015 Jan;56(1):31-40.
- doi: 10.4111/kju.2015.56.1.31
PURPOSE: To compare the expression of survivin and its association with clinicopathological criteria in major types of urinary bladder carcinoma, specifically, transitional cell carcinoma with and without squamous differentiation and... -
- CITED
-
- Close
- SHARE
-
- Close
- Altered Gene Expression Profile After Exposure to Transforming Growth Factor beta1 in the 253J Human Bladder Cancer Cell Line
-
Lee C, Lee SH, Kim DS, Jeon YS, Lee NK, Lee SE
- KMID: 1794590
- Korean J Urol.
- 2014 Aug;55(8):542-550.
- doi: 10.4111/kju.2014.55.8.542
PURPOSE: Transforming growth factor beta1 (TGF-beta1) inhibits the growth of bladder cancer cells and this effect is prominent and constant in 253J bladder cancer cells. We performed a microarray analysis... -
- CITED
-
- Close
- SHARE
-
- Close
- Impaired Delta NP63 Expression is Associated with Poor Tumor Development in Transitional Cell Carcinoma of the Bladder
-
He Y, Wu X, Tang W, Tian D, Luo C, Yin Z, Du H
- KMID: 1783068
- J Korean Med Sci.
- 2008 Oct;23(5):825-832.
- doi: 10.3346/jkms.2008.23.5.825
The oncogenic isoform of the p63 protein, delta NP63, plays an important role in the pathogenesis of many epithelial carcinomas, and emerging evidences suggest that delta NP63 is a promising... -
- CITED
-
- Close
- SHARE
-
- Close
